Skip Nav Destination
Issues
1 June 2008
-
Cover Image
Cover Image
Constitutively active Ras induces ‘methuosis’, a non-apoptotic form of cell death involving accumulation of vacuoles derived from macropinosomes. U251 glioblastoma cells, stably expressing myc-H-Ras(G12V) under the control of a tetracycline promoter, were incubated with doxycycline for 4 days to induce the expression of myc-tagged Ras. The confocal image clearly shows that myc-H-Ras(G12V) (red) associates with the membrane surrounding the cytoplasmic vacuoles, which were determined to be enlarged macropinosomes. The vacuoles delineated by Ras are distinct from the autophagic vacuoles, identified by their reactivity with an antibody against endogenous LC3 (green). For details, see the article by Overmeyer and colleagues on page 965. - PDF Icon PDF LinkTable of Contents
ISSN 1541-7786
EISSN 1557-3125
Molecular Cancer Research
Table of Contents
Subject Reviews
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cancer Genes and Genomics
Cell Cycle Regulator Gene CDC5L, a Potential Target for 6p12-p21 Amplicon in Osteosarcoma
Xin-Yan Lu; Yaojuan Lu; Yi-Jue Zhao; Kim Jaeweon; Jason Kang; Li Xiao-Nan; Gouqing Ge; Rene Meyer; Laszlo Perlaky; John Hicks; Murali Chintagumpala; Wei-Wen Cai; Marc Ladanyi; Richard Gorlick; Ching C. Lau; Debananda Pati; Michael Sheldon; Pulivarthi H. Rao
Cell Cycle, Cell Death, and Senescence
DNA Damage and Cellular Stress Responses
Activation of Epidermal Growth Factor Receptor and Its Downstream Signaling Pathway by Nitric Oxide in Response to Ionizing Radiation
Hyung-Chahn Lee; Sungkwan An; Hansoo Lee; Sang-Hyeok Woo; Hyeon-Ok Jin; Sung-Keum Seo; Tae-Boo Choe; Doo-Hyun Yoo; Su-Jae Lee; Young-Joon Hong; Myung-Jin Park; Chang-Hun Rhee; In-Chul Park; Seok-Il Hong
Signaling and Regulation
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.